Cardiac Arrhythmia Pilot Study (CAPS)
Launched by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI) · Oct 27, 1999
Trial Information
Current as of January 15, 2025
Completed
Keywords
ClinConnect Summary
BACKGROUND:
Epidemiologic studies had indicated that complex ventricular premature beats made an independent contribution to risk of sudden death in survivors of a myocardial infarction (MI), and did not appear to be merely a reflection of their association with relatively severe myocardial damage. The potential for reduction in mortality by identification and administration of drugs capable of safely suppressing ventricular arrhythmias was tremendous. In 1982, there was incomplete knowledge regarding which types of ventricular arrhythmias responded to various kinds of drugs. A pilot study...
Gender
ALL
Eligibility criteria
- • Men and women. Patients had acute myocardial infarction and ventricular arrhythmias.
Trial Officials
Toshio Akiyama
University of Rochester
Allan Barker
Salt Lake Clinic Research Foundation
J. Bigger
Columbia University
Robert Capone
Rhode Island Hospital
Lawrence Griffith
Johns Hopkins University
Craig Pratt
Baylor College of Medicine
David Richardson
Medical College of Virginia
William Rogers
University of Alabama at Birmingham
Michael Sather
V.A. Medical Center
Israel Stein
Clinical Data, Inc
Pierre Theroux
Montreal Heart Institute
Raymond Woosley
Vanderbilt University Medical Center
About National Heart, Lung, And Blood Institute (Nhlbi)
The National Heart, Lung, and Blood Institute (NHLBI) is a leading component of the National Institutes of Health (NIH), dedicated to advancing research and clinical trials focused on cardiovascular, pulmonary, and hematologic diseases. With a mission to improve public health through innovative research, the NHLBI supports a wide range of studies aimed at understanding, preventing, and treating heart and lung conditions. By collaborating with academic institutions, healthcare providers, and patient communities, the NHLBI strives to translate scientific discoveries into effective clinical practices, ultimately enhancing the quality of life for individuals affected by these critical health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials